Axis Max Life Insurance Limited (“Axis Max Life” / “Company”), formerly known as Max Life Insurance Company Limited, has launched the Axis Max Life Diversified Equity Fund II ULIF04317/12/25DIVIEQUITY104>. This New Fund Offer (NFO) is designed to enable long-term capital appreciation by investing in a portfolio of high-growth companies across the market spectrum. The NFO period is open till April 27, 2026.
The Axis Max Life Diversified Equity Fund II is benchmarked against the NSE Nifty 200 Index. With a mandate to maintain a minimum of 80% exposure to equities, the fund aims to outperform the market through focused stock selection and fundamental research. The remaining 20% of the corpus provides the flexibility to invest in debt instruments and money market papers to balance the portfolio's risk-return profile.
The fund builds upon the track record of the existing Diversified Equity Fund ULIF02201/01/20LIFEDIVEQF104>, which recently received a 4-star rating from Morningstar for its performance relative to the Nifty 200 Index across multiple market cycles.
Key Features of the Fund:
The Axis Max Life Diversified Equity Fund II is suited for investors with a long-term investment horizon, a high-risk appetite, and a preference for actively managed equity exposure. It is particularly relevant for those seeking diversification, professional fund management, and the combined benefits of protection and market-linked growth through ULIPs.
Customers can access the New Fund Offer by visiting - Axis Max Life Diversified Equity Fund II
IRDAI Registration No.: 104
Company Information Number: U74899HR2000PLC143012